IP Library Granted Patent US 7,905,862
Granted Patent B2
US 7,905,862 · App. 11/735,921 · Granted Mar 15, 2011

Method and system for drug delivery

Assignee: Cytyc Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,905,862
App. No.
11/735,921
Granted
Mar 15, 2011
Kind
B2
Abstract

A medical device and procedure for delivering a drug into a uterus are described. In one implementation, the medical device includes a first elongate member, a second elongate member and a stopper device. The first elongate member is configured for transcervical insertion into the uterus and includes a lumen extending therethrough. The second elongate member is positioned within said lumen and also includes a lumen therethrough. The second elongate member is positionable in a retracted or an extended position. A distal end of the second elongate member is configured to extend beyond a distal end of the first elongate member and penetrate uterine tissue when in the extended position. A proximal end of the second elongate member is configured to receive a drug for delivery through the lumen of the second elongate member. The stopper device controls movement of the second elongate member within the first elongate member.

Claims (22)

1. A drug delivery device adapted for insertion into a working channel of a hysteroscope comprising:

a first elongate member configured for transcervical insertion into a uterine cavity, the first elongate member including a proximal end, a distal end and a first lumen, a second lumen and a third lumen extending therethrough between the proximal and distal ends, wherein the second lumen includes light fibers and the third lumen includes a micro-endoscope;

a light post coupler coupled to the light fibers and configured to couple to a light source;

a camera adapter coupled to the micro-endoscope and configured to couple to a camera;

a second elongate member positioned within the first lumen of the first elongate member and including a proximal end, a distal end and a lumen therethrough, where:

the second elongate member is positionable in a retracted or an extended position relative to the first elongate member;

the distal end of the second elongate member is configured to extend beyond the distal end of the first elongate member and pierce uterine tissue when in the extended position;

the proximal end of the second elongate member is configured to receive a drug for delivery through the lumen of the second elongate member; and

a stopper device configured to control movement of the second elongate member within the first elongate member thereby defining the retracted and extended positions of the second elongate member, the stopper device including a first gripping member fixedly secured to the proximal end of the first elongate member and a second gripping member fixedly secured to the proximal end of the second elongate member, where the second gripping member is configured to abut the first gripping member in a non-engaging fashion when the second elongate member is in the extended position.

2. The device of claim 1 , further comprising:

a first connector coupled to the proximal end of the second elongate member and configured to couple to a drug source; and

a second connector coupled to the proximal end of the second elongate member and configured to couple to a distension medium source.

3. The device of claim 2 , wherein at least one of the first and second connectors is a leur connector.

4. The device of claim 1 , wherein the drug is a local anesthetic.

5. The device of claim 1 , wherein the first elongate member is curved.

6. The device of claim 1 , wherein the distal end of the first elongate member is rounded.

7. The device of claim 1 , wherein the second elongate member is a needle.

8. The device of claim 1 , wherein the distal end of the second elongate member is configured to extend approximately 1 to 10 mm beyond the distal end of the first elongate member.

9. The device of claim 1 , further comprising:

a drug source coupled to the proximal end of the second elongate member.

10. The device of claim 9 , further comprising:

a distension medium source coupled to the proximal end of the second elongate member.

Assignments (8)
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS Recorded Aug 26, 2010
From: GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT
To: HOLOGIC, INC.; R2 TECHNOLOGY, INC.; SUROS SURGICAL SYSTEMS, INC.; BIOLUCENT, LLC; DIRECT RADIOGRAPHY CORP.; CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS LIMITED PARTNERSHIP; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS III, INC.; CYTYC PRENATAL PRODUCTS CORP.; THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 024892/0001 →
PATENT SECURITY AGREEMENT Recorded Jul 29, 2008
From: CYTYC SURGICAL PRODUCTS
To: GOLDMAN SACHS CREDIT PARTNERS L.P., AS COLLATERAL AGENT
Reel/Frame 021311/0118 →
PATENT SECURITY AGREEMENT Recorded Oct 26, 2007
From: CYTYC SURGICAL PRODUCTS
To: GOLDMAN SACHS CREDIT PARTNERS L.P.
Reel/Frame 020018/0653 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2007
From: SAMPSON, RUSSEL M.
To: CYTYC CORPORATION
Reel/Frame 019462/0564 →
Continuity (3)
Division 11280979 · Nov 15, 2005
Provisional Application 60627684 · Nov 15, 2004
Related Publication 20070185435A1 · Aug 9, 2007